A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Sloan Kettering Basking Ridge (all Protocol Activities)
Basking Ridge, New Jersey, United States
Recruiting - Memorial Sloan Kettering Monmouth (all Protocol Activities)
Middletown, New Jersey, United States
Recruiting - Memorial Sloan Kettering Bergen (all Protocol Activities)
Montvale, New Jersey, United States
Recruiting - Memorial Sloan Kettering Cancer Center Suffolk - Commack (all Protocol Activities)
Commack, New York, United States
Recruiting - Memorial Sloan Kettering Westchester (all Protocol Activities)
East White Plains, New York, United States
Recruiting - Memorial Sloan Kettering Cancer Center (all Protocol Activities)
New York, New York, United States
Alan Ho, MD, PhDRecruiting - Memorial Sloan Kettering Nassau (all Protocol Activities)
Uniondale, New York, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2025
- Primary completion
- 31 Mar 2027
- Completion
- 31 Mar 2027
- Last update posted
- 6 Aug 2026
- Registered enrollment
- 34
- Registry id
- NCT06891560
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.